Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

William E. Dager · SciRah

Researcher profile · Semantic Scholar

William E. Dager

Share profile

William E. Dager — researcher profile on SciRah

h-index: 35
Works: 134
Citations: 4,457

Most-cited papers

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
G. Barnes, Allison E. Burnett, Arthur L. Allen, Marilyn Blumenstein +8 more
2020Journal of Thrombosis and Thrombolysis425 citations Open access
Semantic Scholar
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.
J. Douketis, A. Spyropoulos, M. Murad, J. Arcelus +10 more
2022Chest339 citations
Semantic Scholar
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
E. Nutescu, Sarah A. Spinier, A. Wittkowsky, William E. Dager
2009The Annals of Pharmacotherapy292 citations
Semantic Scholar
Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis
Brett H. Heintz, G. Matzke, William E. Dager
2009Pharmacotherapy176 citations
Semantic Scholar
Removal of dabigatran by hemodialysis.
Don N. Chang, William E. Dager, A. Chin
2013American Journal of Kidney Diseases165 citations Open access
Semantic Scholar
Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update
Brian M. Hoff, J. H. Maker, William E. Dager, Brett H. Heintz
2020The Annals of Pharmacotherapy117 citations
Semantic Scholar
Dabigatran Effects on the International Normalized Ratio, Activated Partial Thromboplastin Time, Thrombin Time, and Fibrinogen: A Multicenter, In Vitro Study
William E. Dager, R. Gosselin, S. Kitchen, Dennis Dwyre
2012The Annals of Pharmacotherapy111 citations
Semantic Scholar
Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity
William E. Dager, R. Gosselin, A. Roberts
2013Critical Care Medicine99 citations
Semantic Scholar
Bivalirudin in Pediatric Patients Maintained on Extracorporeal Life Support
Erin L. Nagle, William E. Dager, J. Duby, A. Roberts +3 more
2013Pediatric Critical Care Medicine98 citations
Semantic Scholar
Racial and gender differences in the incidence of recurrent venous thromboembolism
R. White, William E. Dager, Hong Zhou, S. Murin
2006Thrombosis and Haemostasis93 citations
Semantic Scholar
Laboratory Monitoring of Parenteral Direct Thrombin Inhibitors
E. Van Cott, A. J. Roberts, William E. Dager
2017Seminars in Thrombosis and Hemostasis81 citations
Semantic Scholar
Drug-induced thrombocytopenia in critically ill patients
Jennifer L. Priziola, M. Smythe, William E. Dager
2010Critical Care Medicine73 citations
Semantic Scholar
Reversal of Elevated International Normalized Ratios and Bleeding with Low‐Dose Recombinant Activated Factor VII in Patients Receiving Warfarin
William E. Dager, J. H. King, Ron C. Regalia, Dean Williamson +4 more
2006Pharmacotherapy73 citations
Semantic Scholar
Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban
R. Gosselin, Suzanne J. Francart, Emily M. Hawes, S. Moll +2 more
2015The Annals of Pharmacotherapy65 citations
Semantic Scholar
Management of bleeding and reversal strategies for oral anticoagulants: clinical practice considerations.
E. Nutescu, William E. Dager, J. Kalus, J. Lewin +1 more
2013American Journal of Health-System Pharmacy61 citations
Semantic Scholar
Bivalirudin Dosing Adjustments for Reduced Renal Function with or Without Hemodialysis in the Management of Heparin-Induced Thrombocytopenia
Laura Tsu, William E. Dager
2011The Annals of Pharmacotherapy61 citations
Semantic Scholar
Heparin‐Induced Thrombocytopenia: Treatment Options and Special Considerations
William E. Dager, J. Dougherty, P. H. Nguyen, Michael A. Militello +1 more
2007Pharmacotherapy60 citations
Semantic Scholar
Systemic anticoagulation considerations in chronic kidney disease.
William E. Dager, T. Kiser
2010Advances in Chronic Kidney Disease58 citations
Semantic Scholar
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline Executive Summary.
J. Douketis, A. Spyropoulos, M. Murad, Juan I. Arcelus +10 more
2022Chest57 citations
Semantic Scholar
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
G. Barnes, Allison E. Burnett, Arthur L. Allen, J. Ansell +12 more
2022Journal of Thrombosis and Thrombolysis54 citations Open access
Semantic Scholar
Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.
M. Gulseth, G. Grice, William E. Dager
2009American Journal of Health-System Pharmacy49 citations
Semantic Scholar
An Opinion Paper Outlining Recommendations for Training, Credentialing, and Documenting and Justifying Critical Care Pharmacy Services
William E. Dager, S. Bolesta, G. Brophy, Kamila A. Dell +16 more
201147 citations Open access
Semantic Scholar
Implementing anticoagulation management by pharmacists in the inpatient setting.
William E. Dager, M. Gulseth
2007American Journal of Health-System Pharmacy47 citations
Semantic Scholar
Measuring Dabigatran Concentrations Using a Chromogenic Ecarin Clotting Time Assay
R. Gosselin, D. Dwyre, William E. Dager
2013The Annals of Pharmacotherapy45 citations
Semantic Scholar
The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
D. Nishijima, William E. Dager, R. Schrot, J. Holmes
2010Academic Emergency Medicine45 citations
Semantic Scholar
Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants.
William E. Dager, A. J. Roberts, D. Nishijima
2019Thrombosis Research44 citations
Semantic Scholar
Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia.
K. Janatpour, R. Gosselin, William E. Dager, Andrew W. Lee +3 more
2007American Journal of Clinical Pathology39 citations Open access
Semantic Scholar
Dabigatran Etexilate in Clinical Practice: Confronting Challenges to Improve Safety and Effectiveness
M. Gulseth, A. Wittkowsky, J. Fanikos, S. Spinler +2 more
2011Pharmacotherapy36 citations
Semantic Scholar
Vitamin K Dosing to Reverse Warfarin Based on INR, Route of Administration, and Home Warfarin Dose in the Acute/Critical Care Setting
Laura Tsu, J. Erin Dienes, William E. Dager
2012The Annals of Pharmacotherapy35 citations
Semantic Scholar
Aminoglycosides in Intermittent Hemodialysis: Pharmacokinetics with Individual Dosing
William E. Dager, J. H. King
2006The Annals of Pharmacotherapy35 citations
Semantic Scholar
Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy
Elizabeth A. Walker, A. J. Roberts, Erin L. Louie, William E. Dager
2019ASAIO journal (1992)33 citations
Semantic Scholar
Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients.
Tiffany Pon, William E. Dager, A. J. Roberts, R. White
2014Thrombosis Research30 citations
Semantic Scholar
Using Prothrombin Complex Concentrates to Rapidly Reverse Oral Anticoagulant Effects
William E. Dager
2011The Annals of Pharmacotherapy30 citations
Semantic Scholar
The Need for PGY2‐Trained Clinical Pharmacy Specialists
K. Ragucci, C. O'Bryant, K. B. Campbell, M. Buck +8 more
2014Pharmacotherapy27 citations
Semantic Scholar
Bivalirudin for Anticoagulation During Hypothermic Cardiopulmonary Bypass and Recombinant Factor VIIa for Iatrogenic Coagulopathy
Erin L. Nagle, Laura Tsu, William E. Dager
2011The Annals of Pharmacotherapy27 citations
Semantic Scholar
Systemic Anticoagulant Prophylaxis for Central Catheter–Associated Venous Thrombosis in Cancer Patients
A. Chan, A. Iannucci, William E. Dager
2007The Annals of Pharmacotherapy25 citations
Semantic Scholar
Rivaroxaban: Practical Considerations for Ensuring Safety and Efficacy
M. Smythe, J. Fanikos, M. Gulseth, A. Wittkowsky +3 more
2013Pharmacotherapy24 citations
Semantic Scholar
The Joint Commission National Patient Safety Goals (NPSG) directing anticoagulation safety in the United States
R. Gosselin, A. Roberts, William E. Dager
2019Annals of Blood23 citations Open access
Semantic Scholar
Key Articles and Guidelines for the Prevention of Venous Thromboembolism
P. Dobesh, A. Wittkowsky, Zachary A. Stacy, William E. Dager +6 more
2009Pharmacotherapy23 citations
Semantic Scholar
Incomplete dabigatran reversal with idarucizumab
A. Steele, Jin A. Lee, William E. Dager
2018Clinical toxicology22 citations
Semantic Scholar
Developing a management plan for oral anticoagulant reversal.
William E. Dager
2013American Journal of Health-System Pharmacy21 citations Open access
Semantic Scholar
Critical Pathways: The Role of Pharmacy Today and Tomorrow
P. Dobesh, J. Bosso, Suzanne B. Wortman, William E. Dager +3 more
2006Pharmacotherapy21 citations
Semantic Scholar
Effect of telavancin (Vibativ) on routine coagulation test results.
R. Gosselin, William E. Dager, A. Roberts, L. Freeman +3 more
2011American Journal of Clinical Pathology20 citations
Semantic Scholar
Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients.
Caitlin E. Kulig, Kendra J. Schomer, Hugh B. Black, William E. Dager
2020ASAIO journal (1992)19 citations Open access
Semantic Scholar
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of Performance.
William E. Dager, J. Ansell, G. Barnes, Allison E. Burnett +4 more
2020Joint Commission Journal on Quality and Patient Safety19 citations Open access
Semantic Scholar
Current knowledge on assessing the effects of and managing bleeding and urgent procedures with direct oral anticoagulants.
William E. Dager, Thaddaus R. Hellwig
2016American Journal of Health-System Pharmacy19 citations Open access
Semantic Scholar
Pharmacotherapy Considerations in Advanced Cardiac Life Support
William E. Dager, C. Sanoski, B. S. Wiggins, J. Tisdale
2006Pharmacotherapy19 citations Open access
Semantic Scholar
Warfarin for Venous Thromboembolism Prophylaxis After Elective Hip or Knee Arthroplasty: Exploring the Evidence, Guidelines, and Challenges Remaining
William E. Dager
2012The Annals of Pharmacotherapy18 citations
Semantic Scholar
Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations
Jonathan Bain, A. Flannery, J. Flynn, William E. Dager
2017Journal of Thrombosis and Thrombolysis16 citations
Semantic Scholar
Reversing the anticoagulation effects of dabigatran
William E. Dager, L. Banares
2017Hospital Practice16 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Gosselin×7
Invite
R. Gosselin — researcher profile on SciRah
E. Nutescu×5
Invite
E. Nutescu — researcher profile on SciRah
A. Wittkowsky×4
Invite
A. Wittkowsky — researcher profile on SciRah
A. Roberts×4
Invite
A. Roberts — researcher profile on SciRah

×4

Invite

M. Gulseth — researcher profile on SciRah

Invite

G. Barnes — researcher profile on SciRah

Allison E. Burnett×3

Invite

Allison E. Burnett — researcher profile on SciRah

S. Deitelzweig×3

Invite

S. Deitelzweig — researcher profile on SciRah

Invite

S. Kaatz — researcher profile on SciRah

Tracy Minichiello×3

Invite

Tracy Minichiello — researcher profile on SciRah

A. J. Roberts×3

Invite

A. J. Roberts — researcher profile on SciRah

Invite

M. Smythe — researcher profile on SciRah